# Ally Bridge Group (NY) LLC: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 1822947.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $113.1m
- Positions: 25 (25 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1822947/000119312526352338/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [DEFINIUM THERAPEUTICS INC (DFTX)](/companies/dftx.md) | COM SHS | $18.8m | 16.6% | 400,000 | Call | New +400,000 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $16.7m | 14.7% | 125,000 | Call | New +125,000 |
| [MINERVA NEUROSCIENCES INC (NERV)](/companies/nerv.md) | COM NEW | $12.1m | 10.7% | 2,175,802 |  | Added +520,302 |
| [PROMIS NEUROSCIENCES INC (PMN)](/companies/pmn.md) | COM SHS | $8.2m | 7.2% | 620,319 |  | Added +206,100 |
| [FIRST TRACKS BIOTHERAPEUTICS (TRAX)](/companies/trax.md) | ORD SHS | $5.7m | 5.1% | 284,287 |  | New +284,287 |
| [AXSOME THERAPEUTICS INC (AXSM)](/companies/axsm.md) | COM | $4.0m | 3.6% | 16,493 |  | New +16,493 |
| [ASSEMBLY BIOSCIENCES INC (ASMB)](/companies/asmb.md) | COM NEW | $3.8m | 3.4% | 140,000 |  | New +140,000 |
| [WHITEHAWK THERAPEUTICS INC (WHWK)](/companies/whwk.md) | COM | $3.7m | 3.3% | 817,939 |  | Unchanged |
| [EDGEWISE THERAPEUTICS INC (EWTX)](/companies/ewtx.md) | COM | $3.4m | 3.0% | 83,300 |  | Reduced −77,700 |
| [CLIMB BIO INC (CLYM)](/companies/clym.md) | COM | $3.2m | 2.9% | 249,172 |  | New +249,172 |
| [KURA ONCOLOGY INC (KURA)](/companies/kura.md) | COM | $3.2m | 2.8% | 290,000 |  | New +290,000 |
| [CYTOMX THERAPEUTICS INC. (CTMX)](/companies/ctmx.md) | COM | $2.9m | 2.6% | 775,000 |  | Reduced −125,000 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | SPONSORED ADS | $2.8m | 2.5% | 150,000 |  | New +150,000 |
| [PALISADE BIO INC (PALI)](/companies/pali.md) | COM | $2.6m | 2.3% | 1,229,000 |  | New +1,229,000 |
| [SOLID BIOSCIENCES INC (SLDB)](/companies/sldb.md) | COM | $2.6m | 2.3% | 255,959 |  | Reduced −511,015 |
| [AN2 THERAPEUTICS INC (ANTX)](/companies/antx.md) | COM | $2.5m | 2.3% | 526,315 |  | Unchanged |
| UROGEN PHARMA LTD | COM | $2.5m | 2.3% | 69,183 |  | Reduced −132,941 |
| [PERSPECTIVE THERAPEUTICS INC (CATX)](/companies/catx.md) | COM NEW | $2.5m | 2.2% | 743,958 |  | Reduced −182,599 |
| [IDEAYA BIOSCIENCES INC (IDYA)](/companies/idya.md) | COM | $2.5m | 2.2% | 67,500 |  | New +67,500 |
| [INVENTIVA SA (IVA)](/companies/iva.md) | ADS | $2.4m | 2.1% | 634,800 |  | Reduced −110,500 |
| [ALUMIS INC (ALMS)](/companies/alms.md) | COM | $2.2m | 1.9% | 76,459 |  | Reduced −90,500 |
| [OVID THERAPEUTICS INC (OVID)](/companies/ovid.md) | COM | $1.7m | 1.5% | 624,561 |  | Reduced −2,193,898 |
| [EUPRAXIA PHARMACEUTICALS INC (EPRX)](/companies/eprx.md) | COM | $1.7m | 1.5% | 252,175 |  | Reduced −408,200 |
| [IBIO INC (IBIO)](/companies/ibio.md) | COM NEW | $682.8k | 0.6% | 390,147 |  | New +390,147 |
| [TRAWS PHARMA INC (TRAW)](/companies/traw.md) | COM | $663.0k | 0.6% | 786,236 |  | New +786,236 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −33,712 |
| [CAPRICOR THERAPEUTICS INC (CAPR)](/companies/capr.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −113,899 |
| [COMPASS PATHWAYS PLC (CMPS)](/companies/cmps.md) | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −1,045,000 |
| [COMPASS THERAPEUTICS INC (CMPX)](/companies/cmpx.md) | COM | $0 | 0.0% | 0 | Call | Sold out −1,000,000 |
| [INHIBIKASE THERAPEUTICS INC (IKT)](/companies/ikt.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −1,325,000 |
| [KARYOPHARM THERAPEUTICS INC (KPTI)](/companies/kpti.md) | COM NEW | $0 | 0.0% | 0 | Call | Sold out −250,000 |
| [MAZE THERAPEUTICS INC (MAZE)](/companies/maze.md) | COM | $0 | 0.0% | 0 | Call | Sold out −100,000 |
| [PRAXIS PRECISION MEDICINES I (PRAX)](/companies/prax.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −32,810 |
| [RELMADA THERAPEUTICS INC (RLMD)](/companies/rlmd.md) | COM | $0 | 0.0% | 0 |  | Sold out −210,525 |
| [REPLIMUNE GROUP INC (REPL)](/companies/repl.md) | COM | $0 | 0.0% | 0 | Call | Sold out −246,900 |
| SOLENO THERAPEUTICS INC | COM | $0 | 0.0% | 0 | Put | Sold out −200,000 |
| SOLENO THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −200,000 |
| [TARSUS PHARMACEUTICALS INC (TARS)](/companies/tars.md) | COM | $0 | 0.0% | 0 |  | Sold out −80,859 |
| UNIQURE NV | SHS | $0 | 0.0% | 0 | Call | Sold out −300,000 |

Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-352338. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.